Home > Cashflow Statement > ORCHID PHARMA

ORCHID PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹25 Cr₹167 Cr₹31 Cr₹-217 Cr₹-165 Cr

What is the latest Cash Flow from Financing Activities ratio of ORCHID PHARMA ?

The latest Cash Flow from Financing Activities ratio of ORCHID PHARMA is ₹25 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹25 Cr
Mar2024₹167 Cr
Mar2023₹31 Cr
Mar2022₹-217 Cr
Mar2021₹-165 Cr

How is Cash Flow from Financing Activities of ORCHID PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹25 Cr
-84.90
Mar2024 ₹167 Cr
435.97
Mar2023 ₹31 Cr
Positive
Mar2022 ₹-217 Cr
Negative
Mar2021 ₹-165 Cr -

Compare Cash Flow from Financing Activities of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹2,727.4 Cr 5.8% -21.8% -43.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,879.0 Cr 1.5% 6.9% 13.1% Stock Analytics
DIVIS LABORATORIES ₹166,620.0 Cr -0.8% 1.7% 14% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,431.0 Cr 3.2% 9% 44.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,070.0 Cr 1.1% 5% 16.4% Stock Analytics
CIPLA ₹107,051.0 Cr 0.3% -1.3% -9% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

5.8%

-21.8%

-43.1%

SENSEX

-5%

-9.6%

3.1%


You may also like the below Video Courses